Reviva Pharmaceuticals Holdings common stock delisted from Nasdaq
Nasdaq removed Reviva Pharmaceuticals Holdings' common stock from listing on July 10, 2026, under Rule 12d2-2(b) for failure to meet continued-listing…
Company
SEC filing news and material events for REVIVA PHARMACEUTICALS HOLDINGS, INC., briefed from primary-source filings.
1 story
Nasdaq removed Reviva Pharmaceuticals Holdings' common stock from listing on July 10, 2026, under Rule 12d2-2(b) for failure to meet continued-listing…